Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
XB-ART-52412
Elife 2016 Sep 30;5. doi: 10.7554/eLife.20272.
Show Gene links Show Anatomy links

Fatty acid analogue N-arachidonoyl taurine restores function of I Ks  channels with diverse long QT mutations.

Liin SI , Larsson JE , Barro-Soria R , Bentzen BH , Larsson HP .


???displayArticle.abstract???
About 300 loss-of-function mutations in the I Ks  channel have been identified in patients with Long QT syndrome and cardiac arrhythmia. How specific mutations cause arrhythmia is largely unknown and there are no approved I Ks  channel activators for treatment of these arrhythmias. We find that several Long QT syndrome-associated I Ks  channel mutations shift channel voltage dependence and accelerate channel closing. Voltage-clamp fluorometry experiments and kinetic modeling suggest that similar mutation-induced alterations in I Ks  channel currents may be caused by different molecular mechanisms. Finally, we find that the fatty acid analogue N-arachidonoyl taurine restores channel gating of many different mutant channels, even though the mutations are in different domains of the I Ks  channel and affect the channel by different molecular mechanisms. N-arachidonoyl taurine is therefore an interesting prototype compound that may inspire development of future I Ks  channel activators to treat Long QT syndrome caused by diverse I Ks  channel mutations.

???displayArticle.pubmedLink??? 27690226
???displayArticle.pmcLink??? PMC5081249
???displayArticle.link??? Elife
???displayArticle.grants??? [+]

Species referenced: Xenopus
Genes referenced: gnl3


???attribute.lit??? ???displayArticles.show???
References [+] :
Anderson, Large-scale mutational analysis of Kv11.1 reveals molecular insights into type 2 long QT syndrome. 2014, Pubmed